Comparative Study of Mycophenolate Mofetil and Methotrexate in Graft-Versus-Host Disease Prophylaxis in Adult Recipients of Related and Unrelated Allo-HSCT

Comparative Study of Mycophenolate Mofetil and Methotrexate in Graft-Versus-Host Disease Prophylaxis in Adult Recipients of Related and Unrelated Allo-HSCT

Background. Although the use of methotrexate (MTX) and mycophenolate mofetil (MMF) for prophylaxis of graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplantation (allo-HSCT) was compared in a large number of studies, the published results are contradictory. This fact provi...

Full description

Bibliographic Details
Main Authors: IS Moiseev, YuA Tarakanova, AL Alyanskii, EV Babenko, MM Kanunnikov, VA Dubkova, EV Morozova, EI Darskaya, OA Slesarchuk, AD Kulagin, SN Bondarenko, BV Afanas’ev
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2018-12-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
allogeneic hematopoietic stem cell transplantation
graft-versus-host disease
prophylaxis
methotrexate
mycophenolate mofetil
Online Access:http://bloodjournal.ru/wp-content/uploads/2018/12/6-1.pdf

Internet

http://bloodjournal.ru/wp-content/uploads/2018/12/6-1.pdf

Similar Items